Previous studies having revealed the existence of a BRAF-activated lncRNA involved in CRC [23] and of a p53-regulated lncRNA [30], we reasoned that oncogenic mutations might influence or be associated with the expression levels of certain lncRNA genes. The gene discussed is TP53; the disease is colorectal carcinoma.